• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一例与使用血管紧张素转换酶抑制剂相关的术后延迟性血管性水肿病例报告。

A Case Report of Delayed Post-operative Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use.

作者信息

Dabek Robert J, Pina Nancy A, Sheber Benjamin A, Axentiev Anna, Scott Michael C

机构信息

General Surgery, Ascension St. Agnes Hospital, Baltimore, USA.

General Surgery, Ross University School of Medicine, Bridgetown, BRB.

出版信息

Cureus. 2021 Oct 15;13(10):e18800. doi: 10.7759/cureus.18800. eCollection 2021 Oct.

DOI:10.7759/cureus.18800
PMID:34692263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8523184/
Abstract

Angiotensin-converting enzyme inhibitors are known to precipitate angioedema. Drug-induced angioedema is rare in the perioperative setting. Even fewer cases described hours following a minor procedure. In this case report, we present a 45-year-old female who developed drug-induced angioedema hours following an obstetric procedure.

摘要

已知血管紧张素转换酶抑制剂可引发血管性水肿。药物性血管性水肿在围手术期较为罕见。在小型手术后数小时出现此类情况的病例更是少之又少。在本病例报告中，我们呈现了一名45岁女性，她在产科手术后数小时出现了药物性血管性水肿。

相似文献

1
A Case Report of Delayed Post-operative Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use.一例与使用血管紧张素转换酶抑制剂相关的术后延迟性血管性水肿病例报告。
Cureus. 2021 Oct 15;13(10):e18800. doi: 10.7759/cureus.18800. eCollection 2021 Oct.
2
[Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors].[血管紧张素转换酶抑制剂治疗期间的迟发性血管性水肿]
Vojnosanit Pregl. 2011 Apr;68(4):372-6. doi: 10.2298/vsp1104372j.
3
Intraoperative angioedema induced by angiotensin II receptor blocker: a case report.血管紧张素 II 受体阻滞剂引起的术中血管性水肿：一例报告。
Patient Saf Surg. 2018 Sep 20;12:27. doi: 10.1186/s13037-018-0174-0. eCollection 2018.
4
Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.检测羧肽酶N和补体成分的基线水平，作为血管紧张素转换酶抑制剂相关血管性水肿的潜在预测指标。
Arch Dermatol. 1997 Aug;133(8):972-5.
5
Benazepril induced isolated visceral angioedema: a rare and under diagnosed adverse effect of angiotensin converting enzyme inhibitors.贝那普利诱发的孤立性内脏血管性水肿：血管紧张素转换酶抑制剂一种罕见且诊断不足的不良反应。
Int J Cardiol. 2007 May 31;118(2):e68-9. doi: 10.1016/j.ijcard.2007.01.011. Epub 2007 Mar 29.
6
Visceral angioedema: an under-recognized complication of angiotensin-converting enzyme inhibitors.内脏血管性水肿：一种未得到充分认识的血管紧张素转换酶抑制剂并发症。
Postgrad Med. 2015 Mar;127(2):215-7. doi: 10.1080/00325481.2015.1001305. Epub 2015 Jan 10.
7
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.血管紧张素转换酶抑制剂相关性血管性水肿中的二肽基肽酶IV
Hypertension. 2008 Jan;51(1):141-7. doi: 10.1161/HYPERTENSIONAHA.107.096552. Epub 2007 Nov 19.
8
Angiotensin converting enzyme inhibitors and delayed onset, recurrent angioedema of the head and neck.血管紧张素转换酶抑制剂与头颈部迟发性复发性血管性水肿
Br Dent J. 2008 Nov 22;205(10):553-6. doi: 10.1038/sj.bdj.2008.982.
9
Late-onset angioedema due to an angiotensin-converting enzyme inhibitor.血管紧张素转换酶抑制剂所致迟发性血管性水肿
Can J Cardiol. 2007 Mar 15;23(4):315-6. doi: 10.1016/s0828-282x(07)70762-6.
10
Use of C1 Inhibitor for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Decreases Mechanical Ventilation Time.使用C1抑制剂治疗血管紧张素转换酶（ACE）抑制剂诱发的血管性水肿可缩短机械通气时间。
J Emerg Med. 2015 Dec;49(6):e173-5. doi: 10.1016/j.jemermed.2015.06.076. Epub 2015 Sep 26.

引用本文的文献

1
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options.血管紧张素转换酶抑制剂诱发的血管性水肿：一例报告及治疗选择综述
Cureus. 2023 Jun 12;15(6):e40320. doi: 10.7759/cureus.40320. eCollection 2023 Jun.
2
Severe Laryngeal Edema after Extubation with Prior Use of ACEi Medications.拔管后出现严重喉水肿且既往使用过血管紧张素转换酶抑制剂类药物。
Kans J Med. 2023 Mar 15;16(1):79-80. doi: 10.17161/kjm.vol16.18945. eCollection 2023.

本文引用的文献

1
Intraoperative angioedema induced by angiotensin II receptor blocker: a case report.血管紧张素 II 受体阻滞剂引起的术中血管性水肿：一例报告。
Patient Saf Surg. 2018 Sep 20;12:27. doi: 10.1186/s13037-018-0174-0. eCollection 2018.
2
Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor.服用血管紧张素转换酶抑制剂患者的麻醉后严重口腔血管性水肿
Case Rep Anesthesiol. 2014;2014:693191. doi: 10.1155/2014/693191. Epub 2014 Nov 6.
3
Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors.与严重复发性血管性水肿相关的危险因素：一种与血管紧张素转换酶抑制剂有关的流行病。
Laryngoscope. 2014 Nov;124(11):2502-7. doi: 10.1002/lary.24777. Epub 2014 Jun 17.
4
A consensus parameter for the evaluation and management of angioedema in the emergency department.用于急诊科血管性水肿评估和管理的共识参数。
Acad Emerg Med. 2014 Apr;21(4):469-84. doi: 10.1111/acem.12341.
5
Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department.对因血管紧张素转换酶抑制剂诱发血管性水肿而前往急诊科就诊的患者进行的多中心研究。
Ann Allergy Asthma Immunol. 2008 Apr;100(4):327-32. doi: 10.1016/S1081-1206(10)60594-7.
6
Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.美国开始使用血管紧张素转换酶抑制剂的退伍军人中血管性水肿的发病率。
Hypertension. 2008 Jun;51(6):1624-30. doi: 10.1161/HYPERTENSIONAHA.108.110270. Epub 2008 Apr 14.
7
Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.简要综述：血管紧张素转换酶抑制剂与血管性水肿：麻醉相关问题
Can J Anaesth. 2006 Oct;53(10):994-1003. doi: 10.1007/BF03022528.
8
Angioedema.血管性水肿
J Am Acad Dermatol. 2005 Sep;53(3):373-88; quiz 389-92. doi: 10.1016/j.jaad.2004.09.032.
9
Plasma bradykinin in angio-oedema.血管性水肿中的血浆缓激肽。
Lancet. 1998 Jun 6;351(9117):1693-7. doi: 10.1016/S0140-6736(97)09137-X.
10
Epidemiological study of angioedema and ACE inhibitors.血管性水肿与血管紧张素转换酶抑制剂的流行病学研究。
Aust N Z J Med. 1996 Dec;26(6):777-82. doi: 10.1111/j.1445-5994.1996.tb00624.x.